FOI release

List of Licensing and Market Status of all Melatonin Immediate-Release Tablets

This request was refused in full, so we didn't provide the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2026/00326

Received 24 March 2026

Published 11 May 2026

Request

I am writing to request information under the Freedom of Information Act regarding melatonin immediate‑release tablets that are licensed in the UK Specifically, I would like to request: A list of all melatonin immediate‑release tablet products that currently hold a valid UK Marketing Authorisation (MA) Please include, where available: * Product name * Strength * Pharmaceutical form * Packsize * MA number * Marketing Authorisation Holder (MAH) * Manufacturer * Indication * License status : Active & Commercialised OR Active & not Commercialised OR Withdrawn OR SUNSET DATE - Active & Non Commercialised [X]

Response

See attached

Documents

• Enter_drug_substance_or_excipient_to_retrieve_current_granted_landscape-final.pdf (101.2 KB)
• FOI2026_00326 (redacted).pdf (1.0 MB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.